Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β(2)-agonists in obstructive lung diseases: a population-based, observational study

BACKGROUND: In 2010, the Icelandic government introduced a new cost-saving policy that limited reimbursement of fixed inhaled corticosteroid/long-acting β(2)-agonist (ICS/LABA) combinations. METHODS: This population-based, retrospective, observational study assessed the effects of this policy change...

Descripción completa

Detalles Bibliográficos
Autores principales: Björnsdóttir, U S, Sigurðardóttir, S T, Jonsson, J S, Jonsson, M, Telg, G, Thuresson, M, Naya, I, Gizurarson, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Respiratory
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309409/
https://www.ncbi.nlm.nih.gov/pubmed/24942308
http://dx.doi.org/10.1111/ijcp.12473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309409/
https://www.ncbi.nlm.nih.gov/pubmed/24942308
http://dx.doi.org/10.1111/ijcp.12473

Ejemplares similares